𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Level of p75 receptor expression in sensory ganglia is modulated by NGF level in the target tissue

✍ Scribed by Kitzman, Patrick H. ;Perrone, Teresa N. ;LeMaster, Ann M. ;Davis, Brian M. ;Albers, Kathryn M.


Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
390 KB
Volume
35
Category
Article
ISSN
0022-3034

No coin nor oath required. For personal study only.

✦ Synopsis


Neurotrophins play an essential role in sensory development by providing trophic support to neurons that innervate peripheral targets. Nerve growth factor (NGF), neurotrophin-3, neurotrophin-4, and brain-derived neurotrophin exert their survival effect by binding to two transmembrane receptor types: trk receptors, which exhibit binding specificity, and the p75NTR receptor, which binds all neurotrophins. To determine how target-derived neurotrophins affect sensory neuron development and function, we used transgenic mice that overexpress NGF in the skin to examine the impact of NGF overexpression on receptor expression. Previous studies of trk expression in trigeminal ganglia of adult NGF transgenics showed that the percentage of trkA neurons doubled and their number increased fivefold. The present study focused on the p75 receptor and shows that the percentage of neurons expressing p75NTR also increase in NGF ganglia, but only by 10%. This increase did not encompass the small, BS-IB-4 isolectin-positive cells as they remained p75 negative in transgenic ganglia. Interestingly, levels of trkA protein were not increased on a per-cell level, whereas levels of p75NTR increased nearly threefold. These results show that in sensory systems, target-derived NGF modulates the level of p75NTR receptor expression, and in so doing, may act to regulate the formation of functional receptor complexes and subsequent trophic action.


📜 SIMILAR VOLUMES


Reducing p75 nerve growth factor recepto
✍ S.S. Cheema; G.L. Barrett; P.F. Bartlett 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 860 KB

The low-affinity p75 receptor for nerve growth factor (p75NGFR) has been implicated in mediating neuronal cell death in vitro. A recent in vitro study from our laboratory showed that the death of sensory neurons can be prevented by reducing the levels of p75NGFR with antisense oligonucleotides. To d

p75 Neurotrophin receptor is implicated
✍ Tracy D. Wilson-Gerwing; Jayne M. Johnston; Valerie M.K. Verge 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 643 KB

## Abstract Neurotrophin‐3 (NT‐3) can negatively modulate trkA and associated phenotype in intact sensory neurons, while positively regulating trkC and associated phenotype. How NT‐3 effects this response is not clear. Whether NT‐3 exerts a differential influence on levels of activated ERK1/2 signa

Expression of the low-affinity neurotrop
✍ Steven Petratos; Michael F. Gonzales; Michael F. Azari; Mark Marriott; Rebecca A 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 1008 KB

## Abstract Precursor cells have the capacity to repopulate the demyelinated brain, but the molecular mechanisms that facilitate their recruitment are largely unknown. The low‐affinity neurotrophin receptor, p75^NTR^, may be one of these regulators; however, its expression profile by oligodendrogli

The expression levels of the transcripti
✍ Cristina Peña; José Miguel García; Vanesa García; Javier Silva; Gemma Domínguez; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 375 KB

## Abstract ZEB1 and SNAIL repress __CDH1__ and induce epithelial–mesenchymal transition (EMT). However, SNAIL and ZEB1 also activate or regulate other target genes in different ways. For instance, vitamin D receptor (VDR), which activates __CDH1__ expression upon ligand binding, is repressed by SN

Inhibition of proliferation and inductio
✍ Manuela Campiglio; Alberta Locatelli; Clelia Olgiati; Nicola Normanno; Giulia So 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB 👁 2 views

High expression of the epidermal growth factor receptor (EGFR) in breast carcinoma confers a growth advantage to the tumor cells. The EGFR tyrosine kinase inhibitor (EGFR-TKI) ZD1839 ('Iressa') has clinical activity in a wide range of tumor types, although the mechanism(s) by which it exerts its ant

High levels of MMP-1 expression in the a
✍ Ulrike Benbow; Grant B. Tower; Colby A. Wyatt; Giovanna Buttice; Constance E. Br 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 302 KB 👁 2 views

Matrix metalloproteinase-1 (MMP-1) is one of only a few enzymes with the ability to degrade the stromal collagens (types I and III) at neutral pH, and high expression of MMP-1 has been associated with aggressive and invasive cancers. We recently reported a single nucleotide insertion/deletion polymo